Research programme: myocardial signal transducers - Millennium

Drug Profile

Research programme: myocardial signal transducers - Millennium

Alternative Names: Myocardial signal transducers research programme - Millennium

Latest Information Update: 28 Jun 2006

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Millennium Pharmaceuticals
  • Class
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Heart failure; Myocardial ischaemia

Most Recent Events

  • 21 Jun 2006 No development reported - Preclinical for Myocardial ischaemia in USA (unspecified route)
  • 20 Jun 2006 No development reported - Preclinical for Congestive heart failure in USA (unspecified route)
  • 21 Mar 2002 COR Therapeutics has been acquired by, and integrated into, Millennium Pharmaceuticals
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top